AI assistant
Sending…
XBiotech Inc. — Director's Dealing 2021
Nov 23, 2021
34229_dirs_2021-11-23_6e79dd98-e9c1-492b-b2fb-bec32d791b8f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2021-11-19
Reporting Person: SHIVASWAMY SUSHMA (Chief Scientific Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-19 | Stock Option | $12.67 | A | 100000 | Acquired | 2031-11-19 | Common Stock (100000) | Direct |
More from XBiotech Inc.
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Apr 29
Major Shareholding Notification
2026
Jan 23
Major Shareholding Notification
2026
Jan 23
Regulatory Filings
2025
Dec 9
Interim / Quarterly Report
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12